wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34859794-8E5BDC28-C854-4FF2-B599-4EC8CBBDA00A
Q34859794-8E5BDC28-C854-4FF2-B599-4EC8CBBDA00A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34859794-8E5BDC28-C854-4FF2-B599-4EC8CBBDA00A
Cancer immunotherapy and breaking immune tolerance: new approaches to an old challenge.
P2860
Q34859794-8E5BDC28-C854-4FF2-B599-4EC8CBBDA00A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34859794-8E5BDC28-C854-4FF2-B599-4EC8CBBDA00A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5a439d7b0b42846404ab443c0571b60465b16e01
P2860
Trial watch: FDA-approved Toll-like receptor agonists for cancer therapy.